Evidence map›Paper›PMID 37882474›Full record

ArticleMicrobial biotechnology2023

Combining multi-omics analysis to identify host-targeted targets for the control of Brucella infection.

Jiuwang Yu, Hongwei Yuan, Jiarong Guo, Zhiheng Dong, Sha Li, Quan Fu, Bilige Aode, Sachula Baoyin, Lidao Bao, Lan Wu

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jiuwang YuTCM Hospital of Mongolian Medicine in Hohhot, Hohhot, China.
Hongwei YuanDepartment of Pathology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Jiarong GuoTCM Hospital of Mongolian Medicine in Hohhot, Hohhot, China.
Zhiheng DongDepartment of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Sha LiDepartment of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Quan FuDepartment of Laboratory, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Bilige AodeDepartment of Mongolian Medicine, Inner Mongolia Xilin Gol League Mongolian Medical Hospital, Xilinhaote, China.
Sachula BaoyinMongolia Medical School, Inner Mongolia Medical University, Hohhot, China.
Lidao BaoTCM Hospital of Mongolian Medicine in Hohhot, Hohhot, China.ORCID 0000-0002-8485-3566
Lan WuTCM Hospital of Mongolian Medicine in Hohhot, Hohhot, China.
Inner Mongolia Medical University · CNHohhot First Hospital · CNInner Mongolia International Mongolian Hospital · CN

Funding

Inner Mongolia Autonomous Region "Prairie excellence" ProjectMajor Project of Natural Science Foundation of Inner Mongolia Autonomous Region 2021ZD14Major projects of Inner Mongolia Natural Science Foundation 2023ZD15National Natural Science Foundation 82160794Natural Science Foundation of Inner Mongolia 2020MS08046"Prairie Talents" Leading Talent Project in Inner Mongolia Autonomous RegionScience and Technology Planning Project of Inner Mongolia Autonomous Region 2020GG0138Technology Planning Project of Inner Mongolia Autonomous Region 2020GG0138Western Light Young Scholars Program of the Chinese Academy of Sciences
6 · The paper itself

Abstract

Human infections caused by Brucella (called brucellosis) are among the most common zoonoses worldwide with an estimated 500,000 cases each year. Since chronic Brucella infections are extremely difficult to treat, there is an urgent need for more effective therapeutics. As a facultative intracellular bacterium, Brucella is strictly parasitic in the host cell. Here, we performed proteomic and transcriptomic and metabolomic analyses on Brucella infected patients, mice and cells that provided an extensive "map" of physiological changes in brucellosis patients and characterized the metabolic pathways essential to the response to infection, as well as the associated cellular response and molecular mechanisms. This is the first report utilizing multi-omics analysis to investigate the global response of proteins and metabolites associated with Brucella infection, and the data can provide a comprehensive insight to understand the mechanism of Brucella infection. We demonstrated that Brucella increased nucleotide synthesis in the host, consistent with increased biomass requirement. We also identified IMPDH2, a key regulatory complex that controls nucleotide synthesis during Brucella infection. Pharmacological targeting of IMPDH2, the rate-limiting enzyme in guanine nucleotide biosynthesis, efficiently inhibits B. abortus growth both in vitro and in vivo. Through screening a library of natural products, we identified oxymatrine, an alkaloid obtained primarily from Sophora roots, is a novel and selective IMPDH2 inhibitor. In further in vitro bacterial inhibition assays, oxymatrine effectively inhibited the growth of B. abortus, which was impaired by exogenous supplementation of guanosine, a salvage pathway of purine nucleotides. This moderately potent, structurally novel compound may provide clues for further design and development of efficient IMPDH2 inhibitors and also demonstrates the potential of natural compounds from plants against Brucella.

Indexed as

Brucella abortusBrucellosisAnimalsHumansMiceMultiomicsNucleotidesProteomicsNucleotides

Identifiers

PMID37882474
PMCPMC10686141
OpenAlexW4387950708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.